نبذة مختصرة : Aim. To study the effect of organ-preserving bronchoplastic surgery on long-term treatment outcomes of patients with non-small cell lung cancer (NSCLC ).Material and Methods. The long-term results of surgical treatment of 740 patients with stage I–III NSCLC , who were treated in Ugra from 2002 to 2015, were analyzed. Lobectomy and bilobectomy were performed in 477 patients, and pneumonectomy was performed in 263 patients. Thirty-two patients underwent bronchoplastic lobectomy and bilobectomy. Intraoperative pathological frozen sections of lymph nodes (# 12) of the remaining lobe of the lung were examined in all patients. If metastases in these lymph nodes were not detected, we performed bronchoplastic lobectomy. If metastases in lymph nodes of the remaining lobe were detected, we performed pneumonectomy. The median age of the patients (only male patients) was 55.3 ± 9.9 years. In 19 (59.4 %) patients, sleeve resections were performed on the right side and in 13 (40.6 %) patients, these resections were performed on the left side. There were 15 bronchoplastic lobectomies of type A, 9 of type B, 4 of type C, and 4 of type D. Sleeve resection of the pulmonary artery was performed in 4 patients. In 16 cases (50.0 %), there were no regional metastases (pN0). In 10 (31.3 %) cases, there was pN1, in six – pN2 (18.7 %).Results. There were no cases of postoperative death. Late complications (asymptomatic bronchial stenosis) occurred in 3 (9.4 %) patients. Long-term treatment outcomes were better in patients who underwent organ-preserving bronchoplastic surgery than in patients who underwent pneumonectomy. Median survival was 66 months after bronchoplastic lobectomies and 34 months after pneumonectomies (p=0.01). The 5- and 10-year survival rates in patients who underwent bronchoplastic lobectomies were 52.9 % and 36.2 %, respectively. The corresponding values in patients who underwent pneumonectomies were 38.0 % and 31.9 %, respectively.Conclusion. Organ-preserving bronchoplastic surgery compared to pneumonectomy does not ...
Relation: https://www.siboncoj.ru/jour/article/view/2030/953; Мордовский А.А., Аксарин А.А., Парсаданян А.М., Тер-Ованесов М.Д., Троян П.П. Эпидемиологическая характеристика заболеваемости и смертности от рака легкого в Ханты-Мансийском автономном округе – Югре. Сибирский онкологический журнал. 2021; 20(4): 30–8.; Левченко Е.В., Левченко Н.Е., Юрин Р.И., Михнин А.Е., Ергнян С.М., Барчук А.С., Горохов Л.В., Слугин Е.Н., Гринкевич М.В. Отдалённые результаты бронхопластических оперативных вмешательств по сравнению с пневмонэктомиями при раке лёгкого. Вопросы онкологии. 2017; 63(2): 234–9.; Решетов А.В., Елькин А.В., Николаев Г.В., Степанов С.С. Бронхо- и ангиопластическая лобэктомия как альтернатива пневмонэктомии в лечении немелкоклеточного рака легкого. Вестник хирургии им. И.И. Грекова. 2018; 177(3): 19–24.; Andersson S.E.M., Rauma V.H.S., Sihvo E.I., Rasanen J.V., Ilonen I.K., Salo J.A. Bronchial sleeve resection or pneumonectomy for non-small cell lung cancer: a propensity-matched analysis of long-term results, survival and quality of life. J Thorac Dis 2015; 7(10): 1742–8. doi:10.3978/j.issn.2072-1439.2015.10.62.; Berhet J.-P., Paradela M., Jimenez M.J., Molins L., Gomez-Caro A. Extended Sleeve Lobectomy: One More Step Toward Advoiding Pneumonectomy in Centrally Located Lung Cancer. Ann Thorac Surg. 2013; 96: 1988–97.; D’Andrilli A., Maurizi G., Andreetti C., Ciccone A.M., Ibrahim M., Piraino A., Mariotta S., Venuta F., Rendina E.A. Sleeve Lobectomy Versus Standard Lobectomy for Lung Cancer: Functional and Oncologic Evaluation. Ann Thorac Surg. 2016; 101(5): 1936–42. doi:10.1016/j.athoracsur.2015.11.057.; Hishida T., Aokage K., Yoshida J., Miyoshi T., Tsuboi M. Extended bronchoplasty for locally advanced left lower lobe lung cancer: surgical technique and outcomes. Interact Cardiovasc Thorac Surg. 2018; 27(4): 602–5. doi:10.1093/icvts/ivy081.; Maurizi G., D’Andrilli A., Venuta F, Rendina E.A. Reconstruction of the bronchus and pulmonary artery. J Thorac Dis. 2016; 8: 168–80.; Maurizi G., D’Andrilli A., Venuta F., Rendina E.A. Bronchial and arterial sleeve resection for centrally-located lung cancers. J Thorac Dis. 2016; 8: 872–81. doi:10.21037/jtd.2016.06.48.; Nagayasu T., Yamasaki N., Tsuchiya T., Matsumoto K., Miyazaki T., Hatachi G., Watanabe H., Tomoshige K. The evolution of bronchoplasty and broncho-angioplasty as treatments for lung cancer: evaluation of 30 years of data from a single institution. Eur J Cardiothorac Surg. 2016 Jan; 49(1): 300–6. doi:10.1093/ejcts/ezv065.; Okada M. [Bronchoplasty for lung cancer]. Nihon Geka Gakkai Zasshi. 2016; 117(4): 283–8.; Rea F., Marulli G., Schiavon M., Zuin A, Hamad A-M., Rizzardi G., Perissinotto E., Sartori F. A quarter of a century experience with sleeve lobectomy for non-small cell lung cancer. Eur J Card Thorac Surg. 2008; 34: 488–92.; Sarsam O.M., Dunning J., Pochulu B., Baste J.M. Robot-assisted bronchoplasty using continuous barbed sutures. J Vis Surg. 2018; 4(1): 3. doi:10.21037/jovs.2017.12.14.; Umeda Y., Marui T., Murakawa S., Matsumoto S. Our tips for bronchoplasty using suture holder and tourniquet. Gen Thorac Cardiovasc Surg. 2019; 67(4): 370–1. doi:10.1007/s11748-018-01061-8.; Waseda R., Iwasaki A. Extended sleeve lobectomy: its place in surgical therapy for centrally located non-small cell lung cancer and a review of technical aspects. J Thorac Dis. 2018; 10 (26): 103–8. doi:10.21037/ jtd.2018.07.40.; Yazgan S., Gursoy S., Ucvet A., Yagoi T., Unal M., Samancilar O., Erbaycu A.E. Long-term results of sleeve lobectomy with continuous suture technique in non-small cell lung cancer. Turk J Thorac Cardiovasc Surg. 2019; 27(1): 93–100. doi:10.5606/tgkdc.dergisi.2019.16324.; Yokota K., Okuda K., Fukai I., Nakanishi R. Extended Bronchoplasty Anastomosed between the Left Main and the Superior Segmental Bronchi for Locally Advanced Left Upper Lobe Lung Cancer with Invasion of the Basal Segment. Ann Thorac Cardiovasc Surg. 2020 Aug; 12(8): 4082–89. doi:10.5761/atcs.cr.20-00215.; https://www.siboncoj.ru/jour/article/view/2030
No Comments.